Bachem Holding AG Cash Flow Conversion Efficiency
Bachem Holding AG cash flow conversion efficiency. Based on the latest financial reports, Bachem Holding AG (BANB) has a cash flow conversion efficiency ratio of 0.127x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF185.50 Million ≈ $234.52 Million USD) by net assets (CHF1.46 Billion ≈ $1.84 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Bachem Holding AG (2002–2025)
Cash flow conversion efficiency of Bachem Holding AG from 2002 to 2025. This chart illustrates how Bachem Holding AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View BANB stock price for real-time trading data and today's change.
Bachem Holding AG Cash Flow Conversion Ratio Explained
Bachem Holding AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Bachem Holding AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bachem Holding AG ranked by their cash flow conversion efficiency. Also see Bachem Holding AG stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Grifols S.A.
MC:GRF
|
0.020x |
|
OceanaGold Corporation
TO:OGC
|
0.119x |
|
Gerdau SA ADR
NYSE:GGB
|
0.029x |
|
Blackstone Secured Lending Fund
NYSE:BXSL
|
0.094x |
|
Asseco Poland S.A.
WAR:ACP
|
0.114x |
|
Granite Construction Incorporated
NYSE:GVA
|
0.214x |
|
E Ink Holdings
TWO:8069
|
0.034x |
|
GREEK O.FOOTB. ADR 1/2
F:GF8A
|
0.457x |
Annual Cash Flow Conversion Efficiency for Bachem Holding AG (2002–2025)
The table below shows the annual cash flow conversion efficiency of Bachem Holding AG from 2002 to 2025. Review how much free cash does Bachem Holding AG generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CHF1.46 Billion ≈ $1.84 Billion |
CHF271.36 Million ≈ $343.07 Million |
0.186x | +76.91% |
| 2024-12-31 | CHF1.39 Billion ≈ $1.76 Billion |
CHF146.32 Million ≈ $184.99 Million |
0.105x | -44.41% |
| 2023-12-31 | CHF1.32 Billion ≈ $1.67 Billion |
CHF249.86 Million ≈ $315.90 Million |
0.189x | +138.88% |
| 2022-12-31 | CHF1.17 Billion ≈ $1.48 Billion |
CHF92.65 Million ≈ $117.13 Million |
0.079x | -8.98% |
| 2021-12-31 | CHF1.12 Billion ≈ $1.42 Billion |
CHF97.56 Million ≈ $123.34 Million |
0.087x | -64.01% |
| 2020-12-31 | CHF475.71 Million ≈ $601.43 Million |
CHF115.04 Million ≈ $145.44 Million |
0.242x | +68.51% |
| 2019-12-31 | CHF447.82 Million ≈ $566.16 Million |
CHF64.27 Million ≈ $81.25 Million |
0.144x | +113.92% |
| 2018-12-31 | CHF384.21 Million ≈ $485.75 Million |
CHF25.78 Million ≈ $32.59 Million |
0.067x | -31.19% |
| 2017-12-31 | CHF374.17 Million ≈ $473.05 Million |
CHF36.48 Million ≈ $46.12 Million |
0.097x | -11.85% |
| 2016-12-31 | CHF365.36 Million ≈ $461.92 Million |
CHF40.41 Million ≈ $51.09 Million |
0.111x | -36.38% |
| 2015-12-31 | CHF353.36 Million ≈ $446.75 Million |
CHF61.43 Million ≈ $77.67 Million |
0.174x | +28.55% |
| 2014-12-31 | CHF349.13 Million ≈ $441.40 Million |
CHF47.22 Million ≈ $59.70 Million |
0.135x | -7.57% |
| 2013-12-31 | CHF336.44 Million ≈ $425.35 Million |
CHF49.23 Million ≈ $62.24 Million |
0.146x | +29.70% |
| 2012-12-31 | CHF326.82 Million ≈ $413.19 Million |
CHF36.87 Million ≈ $46.61 Million |
0.113x | +53.09% |
| 2011-12-31 | CHF333.94 Million ≈ $422.19 Million |
CHF24.61 Million ≈ $31.11 Million |
0.074x | -30.57% |
| 2010-12-31 | CHF359.04 Million ≈ $453.92 Million |
CHF38.11 Million ≈ $48.18 Million |
0.106x | -6.83% |
| 2009-12-31 | CHF376.11 Million ≈ $475.50 Million |
CHF42.85 Million ≈ $54.17 Million |
0.114x | +8.81% |
| 2008-12-31 | CHF375.15 Million ≈ $474.30 Million |
CHF39.28 Million ≈ $49.66 Million |
0.105x | -51.81% |
| 2007-12-31 | CHF359.38 Million ≈ $454.35 Million |
CHF78.07 Million ≈ $98.70 Million |
0.217x | +110.59% |
| 2006-12-31 | CHF389.21 Million ≈ $492.07 Million |
CHF40.15 Million ≈ $50.76 Million |
0.103x | +39.27% |
| 2005-12-31 | CHF370.23 Million ≈ $468.07 Million |
CHF27.42 Million ≈ $34.67 Million |
0.074x | -49.88% |
| 2004-12-31 | CHF337.11 Million ≈ $426.20 Million |
CHF49.82 Million ≈ $62.98 Million |
0.148x | +34.89% |
| 2003-12-31 | CHF324.09 Million ≈ $409.74 Million |
CHF35.51 Million ≈ $44.89 Million |
0.110x | -9.56% |
| 2002-12-31 | CHF310.77 Million ≈ $392.89 Million |
CHF37.64 Million ≈ $47.59 Million |
0.121x | -- |
About Bachem Holding AG
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commerci… Read more